| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |